Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision history updated to v3.4.3 with new dates (2026-03-04, 2026-02-12, 2026-02). Previous revision v3.4.2 is superseded.
    Difference
    0.1%
    Check dated 2026-03-08T02:07:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added: Revision: v3.4.2; Deleted: Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T12:57:27.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    This change is a minor revision updating the page from v3.4.0 to v3.4.1 with no visible impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T07:13:04.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Minor UI and labeling updates: glossary display is now shown by default, a 'Last Update Submitted that Met QC Criteria' indicator was added, the FEAR Act data label capitalization changed, and the page revision updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T05:12:58.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 and no longer shows Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-17T03:59:33.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing trial sites across the US and Canada (and included multiple provinces), reflecting expanded site availability. The previous location sublists and the HHS Vulnerability Disclosure link were removed or updated, accompanying a Revision: v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-19T10:52:25.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.